Search results
Results from the WOW.Com Content Network
The biotech industry can be volatile even for relatively large companies. Amgen (NASDAQ: AMGN), one of the more prominent names in the game, just reminded us all of that fact. Let's find out what ...
Shares of Amgen (NASDAQ: AMGN) are down by 6% in the last 30 days as I write this -- a larger-than-normal amount for a large pharma company's stock to fall, especially considering that the market ...
For premium support please call: 800-290-4726 more ways to reach us
Amgen (AMGN) beats Q2 estimates for both earnings and sales. It maintains its previously-issued sales guidance while raising the earnings range. Stock dips.
Amgen Inc. ( NASDAQ:AMGN ) shareholders might be concerned after seeing the share price drop 14% in the last quarter...
Favorable patent ruling related to Enbrel and strong second-quarter results drive Amgen (AMGN) stock 22.6% higher in the past three months.
For premium support please call: 800-290-4726 more ways to reach us
Amgen (AMGN) misses Q1 estimates for both earnings and sales. Shares decline in after-hours trading. Amgen (AMGN) Q1 Earnings, Sales Miss on Low Prices, Stock Down